Today, Explained Baby’s first gene edit
19 snips
Jun 5, 2025 
Jason Mast, a science and biotech writer at Stat News, dives into the groundbreaking treatment of baby KJ, who received experimental gene editing for a fatal condition. The discussion highlights the urgent medical intervention and innovative therapy involving lipid nanoparticles. Mast also explores the ethical controversies surrounding gene editing, from CRISPR babies to the implications of modifying human embryos. Global perspectives on gene editing regulations add another layer to this compelling conversation about the future of medicine.
AI Snips
Chapters
Transcript
Episode notes
Early Diagnosis and Danger
- KJ experienced dangerously high ammonia levels threatening his life shortly after birth.
- Doctors quickly identified a gene mutation causing his condition and considered gene editing as treatment.
Gene Editing Advances Spur Hope
- Advances in gene editing, especially CRISPR, enabled personalized treatments for rare mutations.
- A rapid development effort was launched to create a therapy for KJ within months.
Therapy Success in Baby KJ
- After six months, KJ received the first dose of gene editing therapy with cautious dosing.
- Treatment lowered his ammonia levels, relaxed dietary restrictions, and eliminated the need for liver transplant.